Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer

被引：17

作者：

Alipour S. ^{[1
]}

Kennecke H.F. ^{[1
,2
]}

Woods R. ^{[3
]}

Lim H.J. ^{[1
,2
]}

Speers C. ^{[3
]}

Brown C.J. ^{[3
]}

Gill S. ^{[1
,2
]}

Renouf D.J. ^{[1
,2
]}

Cheung W.Y. ^{[1
,2
]}

机构：

[1] Department of Medicine, University of British Columbia, Vancouver, BC, V5Z 1M9

[2] Division of Medical Oncology, British Columbia Cancer Agency, Vancouver Clinic, Vancouver, BC, V5Z 4E6

[3] Cancer Surveillance and Outcomes, British Columbia Cancer Agency, Vancouver, BC, V5Z 1G1

来源：

Journal of Gastrointestinal Cancer | 2013年 / 44卷 / 2期

关键词：

Body mass index; Body surface area; Colon cancer; Obesity; Outcomes;

D O I：

10.1007/s12029-012-9472-4

中图分类号：

学科分类号：

摘要：

Background Our study aims were to measure the associations between body mass index (BMI) and body surface area (BSA) with outcomes for stage II and III colon cancer and to evaluate if the effect of obesity is modified by disease stage and receipt of adjuvant therapy. Methods Using a prospective cohort of stage II and III colon cancer patients who were referred between 2001 and 2005, we compared 3-year relapse-free survival (3-year RFS), 5- year cancer-specific survival (5-year CSS), and 5-year overall survival (5-year OS) rates among different BMI and BSA categories. Cox proportional-hazards models were constructed to explore the relationships between different body compositions and outcomes while adjusting for confounders. Results Postoperative height and weight were used to classify 913 patients as normal weight (n0424, BMI <25 kg/ m2), overweight (n0319, BMI 25-30 kg/m2), and obese (n0 170, BMI >30 kg/m2). Using Mosteller formula, 684 subjects had normal BSA (≤2.0 m2) and 229 had high BSA (>2.0 m2). Obese subjects experienced similar 3-year RFS (61.9 vs. 66.5 vs. 63.6 %, p00.51), 5-year CSS (65.6 vs. 72.4 vs. 68.0 %, p00.22), and 5-year OS (60.8 vs. 64.0 vs. 62.2 %, p00.69) when compared to overweight subjects and those with normal BMIs, respectively. Likewise, individuals with high BSA had similar outcomes as those with normal BSA (66.2 vs. 63.6 %, p00.64 for 3-year RFS, 70.3 vs. 68.6 %, p00.62 for 5-year CSS, and 64.5 vs. 61.9 %, p0 0.48 for 5-year OS). In Cox models, advanced age, male gender, stage III disease, and poor performance status correlated with inferior RFS, CSS, and OS, but BMI and BSA did not. Conclusions Obesity as measured by either BMI or BSA was not associated with differences in outcomes in stage II and III colon cancer. © Springer Science+Business Media New York 2012.

引用

页码：203 / 210

页数：7

共 25 条

[1]

Siegel R.L., Jemal A., Thun M.J., Hao Y., Ward E.M., Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites, J Natl Med Assoc, 100, pp. 1441-1444, (2008)

[2]

Siegel R.L., Jemal A., Ward E.M., Increase in incidence of colorectal cancer among young men and women in the United States, Cancer Epidemiol Biomarkers Prev, 18, pp. 1695-1698, (2009)

[3]

Siegel R.L., Ward E.M., Jemal A., Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008, Cancer Epidemiol Biomarkers Prev, 21, pp. 411-416, (2012)

[4]

Moghaddam A.A., Woodward M., Huxley R., Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events, Cancer Epidemiol Biomarkers Prev, 16, pp. 2533-2547, (2007)

[5]

Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M., Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies, Lancet, 371, pp. 569-578, (2008)

[6]

Ning Y., Wang L., Giovannucci E.L., A quantitative analysis of body mass index and colorectal cancer: Findings from 56 observational studies, Obes Rev, 11, pp. 19-30, (2010)

[7]

Murphy T.K., Calle E.E., Rodriguez C., Kahn H.S., Thun M.J., Body mass index and colon cancer mortality in a large prospective study, Am J Epidemiol, 152, pp. 847-854, (2000)

[8]

Vincent A.M., Feldman E.L., Control of cell survival by IGF signaling pathways, Growth Horm IGF Res, 12, pp. 193-197, (2002)

[9]

Leroith D., Roberts Jr. C.T., The insulin-like growth factor system and cancer, Cancer Lett, 195, pp. 127-137, (2003)

[10]

Meyerhardt J.A., Niedzwiecki D., Hollis D., Saltz L.B., Mayer R.J., Nelson H., Et al., Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from Cancer and Leukemia Group B 89803, J Clin Oncol, 26, pp. 4109-4115, (2008)

← 1 2 3 →